Amoxycillin + Clavulanic Acid in pharma franchise in Kerala

Amoxycillin + Clavulanic Acid in PCD pharma franchise in West Bengal

Amoxycillin + Clavulanic Acid in top pharma company in Chennai

Amoxycillin + Clavulanic Acid in pcd pharma supplier in Navi Mumbai

Amoxycillin + Clavulanic Acid in phama franchise company in India
Amoxycillin + Clavulanic Acid in phama distributor in Bhubaneswar

Home/Products /amoxycillin-80mg-clavulanic-acid-11-point-4mg-drop

Moxyplit CV Drops

Composition : Amoxycillin (80mg) + Clavulanic Acid (11.4mg) Drops

Dosage Form : Drops

Packaging Type : HDPE+WFI+DROPPER

Packaging : Mono

Price : ₹89/-

Moxyplit CV Drop combines Amoxycillin, a potent antibiotic, with Clavulanic Acid, which protects Amoxycillin from being broken down by bacterial enzymes, thereby enhancing its effectiveness. This dual-action formula targets a broad range of bacterial infections, including respiratory, skin, ear, and urinary tract infections. It is particularly useful in treating infections caused by beta-lactamase producing bacteria, which are resistant to Amoxycillin alone. The pediatric-friendly drop formulation ensures easy and accurate dosing, making it ideal for young children suffering from bacterial infections.

The combination of Amoxycillin and Clavulanic Acid works synergistically to inhibit bacterial cell wall synthesis, leading to the destruction of the bacteria. Clavulanic acid inhibits the action of beta-lactamase enzymes produced by certain bacteria, which would otherwise neutralize the antibiotic's effect. This ensures the antibiotic remains active and effective, allowing it to treat infections that might otherwise be resistant to Amoxycillin.

Read More

About the Product

Moxyplit CV Drop combines Amoxycillin, a potent antibiotic, with Clavulanic Acid, which protects Amoxycillin from being broken down by bacterial enzymes, thereby enhancing its effectiveness. This dual-action formula targets a broad range of bacterial infections, including respiratory, skin, ear, and urinary tract infections. It is particularly useful in treating infections caused by beta-lactamase producing bacteria, which are resistant to Amoxycillin alone. The pediatric-friendly drop formulation ensures easy and accurate dosing, making it ideal for young children suffering from bacterial infections.

The combination of Amoxycillin and Clavulanic Acid works synergistically to inhibit bacterial cell wall synthesis, leading to the destruction of the bacteria. Clavulanic acid inhibits the action of beta-lactamase enzymes produced by certain bacteria, which would otherwise neutralize the antibiotic's effect. This ensures the antibiotic remains active and effective, allowing it to treat infections that might otherwise be resistant to Amoxycillin.

Common side effects may include diarrhea, nausea, vomiting, or rash. Severe allergic reactions and liver issues are rare but possible.

Indicated for the treatment of bacterial infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and ear infections in both adults and children.

Consult a doctor before use if allergic to penicillin or other antibiotics. Use as prescribed; complete the full course of treatment.

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation